statistiche ricercatore

PAROLARO, DANIELA

Distribuzione geografica

Continente	#
NA - Nord America	16.380
EU - Europa	8.605
AS - Asia	4.975
SA - Sud America	628
Continente sconosciuto - Info sul continente non disponibili	151
AF - Africa	81
OC - Oceania	8
Totale	30.828

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	16.195
IT - Italia	4.240
SG - Singapore	1.743
UA - Ucraina	1.457
CN - Cina	964
SE - Svezia	773
VN - Vietnam	744
TR - Turchia	631
HK - Hong Kong	550
BR - Brasile	524
FI - Finlandia	411
DE - Germania	364
IE - Irlanda	356
GB - Regno Unito	286
FR - Francia	285
RU - Federazione Russa	192
CA - Canada	94
IN - India	86
MX - Messico	59
JP - Giappone	57
BD - Bangladesh	49
NL - Olanda	45
PL - Polonia	33
AR - Argentina	32
BE - Belgio	30
ZA - Sudafrica	29
ES - Italia	27
CZ - Repubblica Ceca	24
IQ - Iraq	23
CO - Colombia	19
PK - Pakistan	17
AT - Austria	16
EU - Europa	15
NG - Nigeria	14
MY - Malesia	11
VE - Venezuela	11
AE - Emirati Arabi Uniti	10
CL - Cile	10
EC - Ecuador	10
MA - Marocco	10
IL - Israele	9
JO - Giordania	9
LT - Lituania	9
UZ - Uzbekistan	9
MD - Moldavia	8
NP - Nepal	8
BG - Bulgaria	7
DO - Repubblica Dominicana	7
PY - Paraguay	7
AU - Australia	6
EG - Egitto	6
KR - Corea	6
PH - Filippine	6
PT - Portogallo	6
SA - Arabia Saudita	6
UY - Uruguay	6
DK - Danimarca	5
ID - Indonesia	5
KE - Kenya	5
AL - Albania	4
BO - Bolivia	4
CH - Svizzera	4
CR - Costa Rica	4
HN - Honduras	4
HU - Ungheria	4
JM - Giamaica	4
KZ - Kazakistan	4
PE - Perù	4
AZ - Azerbaigian	3
DZ - Algeria	3
GT - Guatemala	3
OM - Oman	3
PS - Palestinian Territory	3
RO - Romania	3
TN - Tunisia	3
AO - Angola	2
BA - Bosnia-Erzegovina	2
BH - Bahrain	2
CI - Costa d'Avorio	2
GA - Gabon	2
GE - Georgia	2
GR - Grecia	2
IR - Iran	2
LB - Libano	2
LU - Lussemburgo	2
MT - Malta	2
NZ - Nuova Zelanda	2
PA - Panama	2
PR - Porto Rico	2
RS - Serbia	2
SK - Slovacchia (Repubblica Slovacca)	2
SN - Senegal	2
TT - Trinidad e Tobago	2
TW - Taiwan	2
AM - Armenia	1
BB - Barbados	1
BN - Brunei Darussalam	1
BS - Bahamas	1
BT - Bhutan	1
DM - Dominica	1
Totale	30.677

Salva come PNG Salva come JPEG

Città	#
Milan	2.868
Fairfield	1.834
Ashburn	1.288
San Jose	1.153
Woodbridge	1.128
Jacksonville	1.103
Chandler	1.089
Singapore	949
Houston	845
Seattle	800
Wilmington	728
Ann Arbor	659
Cambridge	607
Hong Kong	540
Dearborn	394
Princeton	381
Dublin	355
Izmir	352
Nyköping	349
Council Bluffs	308
Dallas	294
The Dalles	269
Beijing	259
Rome	241
Boardman	224
Dong Ket	218
Como	192
Chicago	189
New York	178
Lauterbourg	174
San Mateo	162
Ho Chi Minh City	108
Los Angeles	98
Santa Clara	95
San Diego	89
Hanoi	83
Ogden	61
Helsinki	60
Washington	60
São Paulo	53
Tokyo	53
Hefei	51
London	51
Kunming	43
Mexico City	41
Orem	41
Munich	40
Guangzhou	39
Norwalk	39
Toronto	36
Nanjing	35
Warsaw	34
Brussels	30
Brooklyn	26
Chennai	26
Montreal	25
Varese	25
Phoenix	24
Ponte Lambro	23
Brno	22
Atlanta	20
Denver	19
Johannesburg	19
Nanchang	19
San Francisco	19
Verona	19
Frankfurt am Main	18
Mcallen	18
Redwood City	18
Kocaeli	17
Berlin	16
Da Nang	16
Düsseldorf	16
Jinan	16
Nuremberg	16
Ankara	15
Manchester	15
Stockholm	15
Cagliari	14
Fuzhou	14
Poplar	14
Shanghai	14
Falls Church	13
Naples	13
Amsterdam	12
Carbonara Al Ticino	12
Edinburgh	12
Boston	11
Kuala Lumpur	11
Mumbai	11
Shenzhen	11
Zhengzhou	11
Abuja	10
Hangzhou	10
Paris	10
Dhaka	9
Shenyang	9
Amman	8
Belo Horizonte	8
Bologna	8
Totale	22.097

Salva come PNG Salva come JPEG

Nome	#
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin	403
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex	321
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats	290
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect	289
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex	283
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice	277
Ruolo della via Ras-ERK nella dipendenza ai cannabinoidi	271
Assay of GTPγS binding in autoradiography	266
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2	262
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.	261
Adolescent exposure to cannabis as a risk factor for psychiatric disorders	260
A molecular basis of analgesic tolerance to cannabinoids	256
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine	254
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex	251
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour	243
MeCP2 related studies benefit from the use of CD1 as genetic background	239
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol.	234
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats.	233
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism	230
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex	227
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats	226
New vistas on cannabis use disorder	222
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence.	220
Long lasting consequences of cannabis exposure in adolescence.	217
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat	216
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling	216
Endocannabinoids and Mental Disorders.	213
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine	212
Ruolo emergente del sistema degli endocannabinoidi nelle malattie neuropsichiatriche	212
Cannabinoids and opioids share cAMP pathway in rat splenocytes	211
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats.	209
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring	205
AM630 behaves as a protean ligand at the human cannabinoid CB(2) receptor.	205
Role of endocannabinoids in regulating drug dependence	204
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function	204
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats.	201
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.	200
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT?	199
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes	197
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect.	196
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood	195
Expression and function of the endocannabinoid system in glial cells.	194
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain	194
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw	193
Sex-dependent vulnerability to cannabis abuse in adolescence	192
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.	190
Endocannabinoids and Drug Dependence	190
Cellular mechanisms underlying the interaction between cannabinoid and opioid system	188
The endocannabinoid system and psychiatric disorders.	188
Cannabinoids and Drugs of abuse	187
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex	187
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance.	186
The endocannabinoid system and schizophrenia: integration of evidence.	183
Neurobiological mechanisms underlying cannabis-induced memory impairment	183
Modulation of rat brain cannabinoid receptors after chronic morphine treatment	180
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain	178
Molecular and cellular basis of cannabinoid and opioid interactions	177
Endocannabinoids in the immune system and cancer	176
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940	176
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats	176
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system	176
Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system	174
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments	171
The phytocannabinoid, delta-9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects	171
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade	170
Cannabidiol inhibits angiogenesis by multiple mechanisms	170
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure	170
A role of nitric oxide in WIN 55,212-2 tolerance in mice.	169
The psychoactive ingredient of marijuana induces behavioural sensitization	168
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251.	167
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects	165
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat	164
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems	164
Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates.	164
Alterazioni cellulari indotte da farmaci d'abuso e da stimoli avversivi non evitabili nel sistema nervoso centrale di ratto	162
Uso di Cannabis in adolescenza come fattore di rischio per malattie psichiatriche e dipendenza da altre sostanze	161
Presence and functional regulation of cannabinoid receptors in immune cells	160
In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors	160
Cholera toxin effects on body temperature changes induced by morphine.	160
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages	159
Alterazioni cellulari e molecolari presenti nel sistema nervoso centrale durante i processi di sensitizzazione a lungo termine indotti da diversi farmaci d'abuso	158
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism.	157
Binding studies of dermorphin and its L-form on rat brain opioid receptors.	157
Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats.	157
Cannabinoids as potential new therapy for the treatment of gliomas.	155
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro.	155
Inhibition of tumor cell migration	155
Pertussis toxin inhibits the antinociceptive action of morphine in the rat..	154
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.	154
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system	153
Presence of a reduced opioid response in interleukin-6 knock out mice	153
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line	153
Antitumor effects of cannabidiol , a nonpsychoative cannabinoid, on Human glioma cell lines	152
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors	152
Cellular mechanisms of Delta(9)-tetrahydrocannabinol behavioural sensitization	151
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models	150
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat.	149
Ruolo emergente dei meccanismi epigenetici e della neuroinfiammazione nei disturbi associate al consume di cannabis	148
Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression.	147
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models	147
Totale	19.630

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	115.893
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	115.893

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	1.738	0	203	182	251	58	89	71	94	94	282	149	265
2022/2023	2.722	265	165	192	326	157	582	10	378	399	75	120	53
2023/2024	4.570	717	743	725	832	902	350	31	76	100	28	23	43
2024/2025	2.706	39	42	483	78	74	174	100	211	349	217	222	717
2025/2026	5.971	424	379	137	792	581	433	1.386	369	702	369	239	160
2026/2027	551	276	275	0	0	0	0	0	0	0	0	0	0
Totale													30.828